January 12, 2018
Nippon Chemiphar said on January 11 that its investigational antidepressant/anti-anxiety agent NC-2800 has been selected for the Japan Agency for Medical Research and Development’s (AMED) Cyclic Innovation for Clinical Empowerment (CiCLE) grant program. NC-2800 is a novel δ opioid receptor...read more